Literature DB >> 27553924

Non-invasive quantification of tumour heterogeneity in water diffusivity to differentiate malignant from benign tissues of urinary bladder: a phase I study.

Huyen T Nguyen1, Zarine K Shah1, Amir Mortazavi2, Kamal S Pohar3, Lai Wei4, Guang Jia5,6, Debra L Zynger7, Michael V Knopp8.   

Abstract

OBJECTIVES: To quantify the heterogeneity of the tumour apparent diffusion coefficient (ADC) using voxel-based analysis to differentiate malignancy from benign wall thickening of the urinary bladder.
METHODS: Nineteen patients with histopathological findings of their cystectomy specimen were included. A data set of voxel-based ADC values was acquired for each patient's lesion. Histogram analysis was performed on each data set to calculate uniformity (U) and entropy (E). The k-means clustering of the voxel-wised ADC data set was implemented to measure mean intra-cluster distance (MICD) and largest inter-cluster distance (LICD). Subsequently, U, E, MICD, and LICD for malignant tumours were compared with those for benign lesions using a two-sample t-test.
RESULTS: Eleven patients had pathological confirmation of malignancy and eight with benign wall thickening. Histogram analysis showed that malignant tumours had a significantly higher degree of ADC heterogeneity with lower U (P = 0.016) and higher E (P = 0.005) than benign lesions. In agreement with these findings, k-means clustering of voxel-wise ADC indicated that bladder malignancy presented with significantly higher MICD (P < 0.001) and higher LICD (P = 0.002) than benign wall thickening.
CONCLUSIONS: The quantitative assessment of tumour diffusion heterogeneity using voxel-based ADC analysis has the potential to become a non-invasive tool to distinguish malignant from benign tissues of urinary bladder cancer. KEY POINTS: • Heterogeneity is an intrinsic characteristic of tumoral tissue. • Non-invasive quantification of tumour heterogeneity can provide adjunctive information to improve cancer diagnosis accuracy. • Histogram analysis and k-means clustering can quantify tumour diffusion heterogeneity. • The quantification helps differentiate malignant from benign urinary bladder tissue.

Entities:  

Keywords:  Apparent Diffusion Coefficient; Bladder malignancy; Histogram analysis; K-means clustering; Tumour heterogeneity

Mesh:

Substances:

Year:  2016        PMID: 27553924      PMCID: PMC5613982          DOI: 10.1007/s00330-016-4549-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Magnetic resonance imaging with k-means clustering objectively measures whole muscle volume compartments in sarcopenia/cancer cachexia.

Authors:  Calum Gray; Thomas J MacGillivray; Clare Eeley; Nathan A Stephens; Ian Beggs; Kenneth C Fearon; Carolyn A Greig
Journal:  Clin Nutr       Date:  2010-08-19       Impact factor: 7.324

2.  Assessment of the residual tumour of colorectal liver metastases after chemotherapy: diffusion-weighted MR magnetic resonance imaging in the peripheral and entire tumour.

Authors:  Mathilde Wagner; Maxime Ronot; Sabrina Doblas; Céline Giraudeau; Bernard Van Beers; Jacques Belghiti; Valérie Paradis; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2015-05-02       Impact factor: 5.315

3.  The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.

Authors:  S Avcu; M N Koseoglu; K Ceylan; M D Bulut; M Dbulutand; O Unal
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

4.  Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Huyen T Nguyen; Kamal S Pohar; Guang Jia; Zarine K Shah; Amir Mortazavi; Debra L Zynger; Lai Wei; Daniel Clark; Xiangyu Yang; Michael V Knopp
Journal:  Invest Radiol       Date:  2014-06       Impact factor: 6.016

5.  Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers.

Authors:  Erlend K F Andersen; Gunnar B Kristensen; Heidi Lyng; Eirik Malinen
Journal:  Acta Oncol       Date:  2011-08       Impact factor: 4.089

6.  Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

Authors:  Katsunori Tatsugami; Kentaro Kuroiwa; Toshiyuki Kamoto; Hiroyuki Nishiyama; Jun Watanabe; Satoru Ishikawa; Nobuo Shinohara; Ataru Sazawa; Shoji Fukushima; Seiji Naito
Journal:  J Endourol       Date:  2010-08-14       Impact factor: 2.942

7.  Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results.

Authors:  Mitsuru Matsuki; Yuki Inada; Fuminari Tatsugami; Masato Tanikake; Isamu Narabayashi; Yoji Katsuoka
Journal:  Eur Radiol       Date:  2006-07-25       Impact factor: 5.315

8.  Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer.

Authors:  Shuichiro Kobayashi; Fumitaka Koga; Kohei Kajino; Soichiro Yoshita; Chikako Ishii; Hiroshi Tanaka; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Tetsuo Yamada; Kazunori Kihara
Journal:  J Magn Reson Imaging       Date:  2013-04-15       Impact factor: 4.813

9.  Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.

Authors:  Huyen T Nguyen; Guang Jia; Zarine K Shah; Kamal Pohar; Amir Mortazavi; Debra L Zynger; Lai Wei; Xiangyu Yang; Daniel Clark; Michael V Knopp
Journal:  J Magn Reson Imaging       Date:  2014-06-19       Impact factor: 4.813

Review 10.  Improving tumour heterogeneity MRI assessment with histograms.

Authors:  N Just
Journal:  Br J Cancer       Date:  2014-09-30       Impact factor: 7.640

View more
  5 in total

1.  Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?

Authors:  Riccardo De Robertis; Bogdan Maris; Nicolò Cardobi; Paolo Tinazzi Martini; Stefano Gobbo; Paola Capelli; Silvia Ortolani; Sara Cingarlini; Salvatore Paiella; Luca Landoni; Giovanni Butturini; Paolo Regi; Aldo Scarpa; Giampaolo Tortora; Mirko D'Onofrio
Journal:  Eur Radiol       Date:  2018-01-19       Impact factor: 5.315

2.  Integrated analysis of 18F-FDG PET/CT improves preoperative lymph node staging for patients with invasive bladder cancer.

Authors:  Antoine Girard; Mathieu Rouanne; Sarah Taconet; Camélia Radulescu; Yann Neuzillet; Astrid Girma; Aurélie Beaufrere; Thierry Lebret; Elise Le Stanc; Jean-François Grellier
Journal:  Eur Radiol       Date:  2019-01-21       Impact factor: 5.315

3.  Prediction of Pancreatic Neuroendocrine Tumor Grading Risk Based on Quantitative Radiomic Analysis of MR.

Authors:  Wei Li; Chao Xu; Zhaoxiang Ye
Journal:  Front Oncol       Date:  2021-11-17       Impact factor: 6.244

4.  Rectal Cancer Invasiveness: Whole-Lesion Diffusion-Weighted Imaging (DWI) Histogram Analysis by Comparison of Reduced Field-of-View and Conventional DWI Techniques.

Authors:  Yang Peng; Hao Tang; Xuemei Hu; Yaqi Shen; Ihab Kamel; Zhen Li; Daoyu Hu
Journal:  Sci Rep       Date:  2019-12-10       Impact factor: 4.379

5.  Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?

Authors:  Huyen T Nguyen; Amir Mortazavi; Kamal S Pohar; Debra L Zynger; Lai Wei; Zarine K Shah; Guang Jia; Michael V Knopp
Journal:  Bladder Cancer       Date:  2017-10-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.